Related Experiment Video
Updated: Jun 22, 2026
09:18
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
[Anesthesia in Duchennes Muscular Dystrophy patient: case report]
Deoclécio Tonelli1, Iglair Pinho, Paula de Camargo Neves Sacco
1Faculdade de Medicina do ABC.
Revista Brasileira De Anestesiologia
|May 29, 2009
Summary
This case report highlights the safe anesthetic management of a Duchennes Muscular Dystrophy patient undergoing surgery. Careful evaluation and monitoring ensured a complication-free procedure and recovery for this pediatric patient.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Neuromuscular Disorders
Context:
- Duchennes Muscular Dystrophy (DMD) is a progressive X-linked recessive disorder impacting respiratory function.
- Surgical procedures in pediatric patients with DMD require specialized anesthetic considerations.
- Postectomy is a common surgical intervention in pediatric males.
Purpose:
- To present a case of Duchennes Muscular Dystrophy managed under general anesthesia with ketamine S for postectomy.
- To evaluate the safety and efficacy of specific anesthetic techniques in DMD patients.
- To emphasize the importance of meticulous pre-anesthetic assessment and intraoperative monitoring.
Summary:
- A 9-year-old male with a 2-year history of Duchennes Muscular Dystrophy underwent postectomy.
- General anesthesia was administered using intravenous levo-ketamine with spontaneous ventilation and a penile block.
- Comprehensive monitoring included non-invasive blood pressure, pulse oximetry, cardioscopy, and esophageal temperature.
Impact:
- The anesthetic management was successful, with no intraoperative incidents.
- The patient experienced only minor postoperative vomiting and was discharged asymptomatic within 24 hours.
- This case underscores that safe surgical and postoperative outcomes are achievable for Duchennes Muscular Dystrophy patients with careful anesthetic planning and execution.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...